Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains

Clinical Microbiology and Infection

Volumn 10, Issue 8, 2004, Pages 724-733

  Stock, Ingo ^a   Burak, S ^a   Wiedemann, B ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Antibiotic susceptibility; Escherichia coli; Identification; Leclercia adecarboxylata; MICs

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ARABINITOL; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CELLOBIOSE; CHLORAMPHENICOL; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; KETOLIDE; LINCOSAMIDE; LINEZOLID; LYSINE DECARBOXYLASE; MALONIC ACID; MINOCYCLINE; NITROFURANTOIN; OXACILLIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBITOL; RIFAMPICIN; ROXITHROMYCIN; SORBITOL; STREPTOGRAMIN; TETRACYCLINE; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; LECLERCIA ADECARBOXYLATA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; VALIDATION PROCESS;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; LECLERCIA ADECARBOXYLATA;

EID: 4544327932     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00892.x     Document Type: Article

References (38)

1. Leclerc H. Étude biochimique d'Enterobacteriaceae pigmentées. Ann Inst Pasteur 1962; 102: 726-740.
2. Richard C. Nouvelles especes d'enterobacteriaceae (1979-1983). Bull Inst Pasteur 1984; 82: 255-277.
3. Izard D, Mergaert J, Gavini F et al. Separation of Escherichia adecarboxylata from the 'Erwinia herbicola-Enterobacter agglomerans' complex and from the other Enterobacteriaceae by nucleic acid and protein electrophoretic techniques. Ann Inst Past Microbiol 1985; 136(suppl B): 151-168.
4. Tamura K, Sakazaki R, Kosako Y, Yoshizaki E. Leclercia adecarboxylata gen. nov., comb. nov., formerly known as Escherichia adecarboxylata. Curr Microbiol 1986; 13: 179-184.
5. Pokhil SL. Species of enterobacteria new to medicine [in Russian]. Mikrobiol Z 1996; 58: 94-103.
6. Richard C. Nouvelles Enterobacteriaceae rencontrées en bactériologie médicale: Moellerella wisconsensis, Koserella trabulsii, Leclercia adecarboxylata, Escherichia fergusonii, Enterobacter asburiae, Rahnella aquatilis. Ann Biol Clin (Paris) 1989; 47: 231-236.
7. Brenner DJ. Additional genera of Enterobacteriaceae. In: Balows A, Trüper HG, Dworkin M, Harder W, Schleifer K-H, eds. The prokaryotes. A handbook on the biology of bacteria: ecophysiology, isolation, identification, applications. New York: Springer, 1992; 2922-2937.
8. Teramoto T, Sakazaki R. Taxonomic analysis of so-called coliform organisms isolated from foods and environmental materials [in Japanese]. J Food Hyg Soc Jpn 1984; 25: 322-328.
9. Cai M, Dong X, Wei J et al. Isolation and identification of Leclercia adecarboxylata in clinical specimens in China [in Chinese]. Wie Sheng Wu Hsueh Pao 1992; 32: 119-123.
10. Daza RM, Iborra J, Alonso N, Vera I, Portero F, Mendaza P. Aislamiento de Leclercia adecarboxylata en patiente cirrótico. Enferm Infecc Microbiol Clin 1993; 11: 53-54.
11. Dudkiewicz B, Szewczyk E. Etiology of bacterial endocarditis in materials from cardiology and cardiac surgery clinics of the Lodz Academy [in Polish]. Med Dosw Mikrobiol 1993; 45: 357-359.
12. Otani E, Bruckner DA. Leclercia adecarboxylata isolated from blood culture. Clin Microbiol Newslett 1991; 13: 157-158.
13. De Baere T, Wauters G, Huylenbroaeck A et al. Isolations of Leclercia adecarboxylata from a patient with a chronically inflamed gallbladder and from a patient with sepsis without focus. J Clin Microbiol 2001; 39: 1674-1675.
14. Fattal O, Deville JG. Leclercia adecarboxylata peritonitis in a child receiving chronic peritoneal dialysis. Pediatr Nephrol 2000; 15: 186-187.
15. Lee NY, Ki CS, Kang WK, Peck KR, Kim S, Song JH. Hickman catheter-associated bacteremia by Leclercia adecarboxylata and Escherichia hermannii: a case report. Kor J Infect Dis 1999; 31: 167-170.
16. Longhurst CA, West DC. Isolation of Leclercia adecarboxylata from an infant with acute lymphoblastic leukemia. Clin Infect Dis 2001; 32: 1659.
17. Martinez MM, Sanchez G, Gomez J, Mendaza P, Daza RM. Aislamiento de Leclercia adecarboxylata en un exudado de ülcera. Enferm Infecc Microbiol Clin 1998; 16: 345.
18. Pérez-Moreno MO, Anguera J, Carulla M, Pérez-Moreno M. Artritis séptica por Leclercia adecarboxylata de origen probablemente yatrogénico. Enferm Infecc Microbiol Clin 2003; 21: 167-168.
19. Rodríguez JA, Sanchez FJ, Gutierrez N, Garcia JE, Garcia-Rodriguez JA. Peritonitis bacteriana por Leclercia adecarboxylata en un paciente sometido a diálisis peritoneal. Enferm Infecc Microbiol Clin 2001; 19: 237-238.
20. Temesgen Z, Toal DR, Cockerill FR. Leclercia adecarboxylata infections. Case report and review. Clin Infect Dis 1997; 25: 79-81.
21. Farmer JJ. Enterobacteriaceae: introduction and identification. In: Murray P, Baron E, Pfaller M, Tenover F, Yolken R, eds. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, 1995; 438-449.
22. Stock I, Wiedemann B. Natural β-lactam susceptibility and mechanisms of β-lactam resistance in Yersinia enterocolitica. Rev Med Microbiol 2000; 38: 1-14.
23. Deutsches Institut für Normung e.V. Susceptibility testing of pathogens to antimicrobial agents, part 4: Evaluation classes of the minimum inhibitory concentration. Supplement 1: MIC breakpoints of antibacterial agents. DIN document 58940-4, Table 1. Berlin: Deutsches Institut für Normung e.V., 2000.
24. Comité de l'Antibiogramme de la Société Franç aise de Microbiologie Communiqué. Statement. Path Biol 1998; 46: I-XVI.
25. Olsson-Liljequist B, Larson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. Part 3: Methology for susceptibility testing. Scand J Infect Dis 1997; 105(suppl): 13-23.
26. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, 5th edn. NCCLS document M7-A5. Villanova, PA: NCCLS, 2000.
27. Stone G, Nilius A, Hensey D, Almer L, Beyer J, Flamm R. Development of tentative interpretive criteria for ABT-773, a novel ketolide antibacterial agent [abstract 2164]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto. Washington, DC: American Society for Microbiology, 2000; 181.
28. Soussy CJ, Goldstein F, Bryskier A et al. Telithromycin: assessment of susceptibility testing [abstract 321]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto. Washington, DC: American Society for Microbiology, 2000; 136.
29. European Committee on Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Linezolid breakpoints. Clin Microbiol Infect 2001; 7: 283-284.
30. Troxler R, von Graevenitz A, Funke G, Wiedemann B, Stock I. Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin Microbiol Infect 2001; 6: 525-535.
31. Gavini F, Mergaert J, Beji A et al. Transfer of Enterobacter agglomerans (Beijerinck 1888) Ewing and Fife 1972 to Pantoea gen. nov. as Pantoea agglomerans comb. nov. and description of Pantoea dispersa sp. nov. Int J Syst Bacteriol 1989; 39: 337-345.
32. Stock I, Wiedemann B. Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains. Diagn Microbiol Infect Dis 1999; 33: 187-199.
33. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrob Chemother 2003; 51: 69-76.
34. O'Hara K. Two different types of fosfomycin resistance in clinical isolates of Klebsiella pneumoniae. FEMS Microbiol Lett 1993; 114: 9-16.
35. Nikaido H. Outer membrane. In: Neinhadt FC, ed. Escherichia coli and Salmonella Typhimurium, cellular and molecular biology. Washington, DC: American Society for Microbiology, 1996; 29-47.
36. Plésiat P, Vaara M. Outer membrane permeability of the antibiotic-supersusceptible lipid A mutants of Escherichia coli to hydrophobic steroid probes. J Antimicrob Chemother 1999; 43: 608-610.
37. Farmer S, Li ZS, Hancock REW. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. J Antimicrob Chemother 1992; 29: 27-33.
38. Hancock REW. Bacterial outer membrane: evolving concepts. Specific structures provide gram-negative bacteria with several unique advantages. ASM Nezvs 1991; 57: 175-182.